Clinical trials / NCT01984762
Recruiting

Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in the Treatment of Type 2 Diabetes Mellitus.

Obesity is a growing epidemic throughout the world and is followed by increasing incidence of type 2 diabetes that accounts for 90-95% of all cases of diabetes. Weight loss is a major objective, although difficult to achieve with medical treatments. Many recent studies demonstrated that bariatric surgery has the potency to achieve marked and sustained weight loss, and is also associated with a significant improvement in control of type 2 diabetes. The principal aim of this study is to compare two types of…

ClinicalTrials.gov IDNCT01984762
PhaseNA
Enrollment134
SponsorGöteborg University
Age18 Years
SexALL
I'm interested View official listing

Conditions studied

Obesity, Type 2 Diabetes, Bariatric Surgery

About this study

Obesity is a growing epidemic throughout the world and is followed by increasing incidence of type 2 diabetes that accounts for 90-95% of all cases of diabetes. Weight loss is a major objective, although difficult to achieve with medical treatments. Many recent studies demonstrated that bariatric surgery has the potency to achieve marked and sustained weight loss, and is also associated with a significant improvement in control of type 2 diabetes. The principal aim of this study is to compare two types of bariatric procedures, the Roux-en-Y gastric bypass (RYGBP) and sleeve gastrectomy (SG). The study hypothesis is that these procedures have equal efficacy with regard to resolution of type 2 diabetes.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: 1. Type 2 diabetes mellitus 2. BMI between 35 and 50kg/m2. 3. Males and females 4. Age between 18 and 60 years. Exclusion Criteria: 1. Severe ongoing psychiatric disorder, alcoholism and substance abuse. 2. Redo operations after previous bariatric procedures. 3. Type 1 diabetes or other non-type 2 forms of diabetes 4. End stage renal disease, retinopathy, neuropathy

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.